Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 29,783 | 21,538 | 16,454 | 12,379 | 16,221 |
| Operating Income | -29,783 | -21,538 | -16,454 | -12,379 | -16,221 |
| Other Income | 72 | 135 | 247 | 493 | 610 |
| Pre-tax Income | -29,711 | -21,403 | -16,207 | -11,886 | -15,611 |
| Net Income Continuous | -29,711 | -21,403 | -16,207 | -11,886 | -15,611 |
| Net Income | $-29,711 | $-21,403 | $-16,207 | $-11,886 | $-15,611 |
| EPS Basic Total Ops | -0.90 | -0.63 | -0.57 | -0.42 | 31.77 |
| EPS Basic Continuous Ops | -0.90 | -0.63 | -0.57 | -0.42 | 31.77 |
| EPS Diluted Total Ops | -0.90 | -0.63 | -0.57 | -0.42 | 31.77 |
| EPS Diluted Continuous Ops | -0.90 | -0.63 | -0.57 | -0.42 | 31.77 |
| EBITDA(a) | $-29,648 | $-21,511 | $-16,413 | $-12,482 | $-16,221 |